tiprankstipranks
The Fly

Elevance Health authorizes $8B increase to common stock repurchase program

Elevance Health authorizes $8B increase to common stock repurchase program

“As of September 30, 2024, the company had approximately $3.1 billion of Board approved share repurchase authorization remaining. On October 15, 2024, our Audit Committee, pursuant to authorization granted by the Board of Directors, authorized an $8.0 billion increase to the common stock repurchase program. The company intends to utilize this authorization over a multi-year period, subject to market and industry conditions.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com